CD274 and triple-negative breast carcinoma: Additionally, in triple-negative breast cancer cells (TNBCs), oleuropein modulates the miR-194/XIST/PD-L1 loop by decreasing PD-L1 and miR-194 levels while upregulating XIST, thereby contributing to its ability to reduce the migration capacity of MDA-MB-231 cells [75].